Global Culture Review
SEE OTHER BRANDS

News on culture, society and lifestyle in the world

Global Culture Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Culture Review.

Press releases published on May 12, 2025

Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference

Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference

LEXINGTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …

Glass House Brands to Hold Investor Sesh IV on Friday, June 20th

Glass House Brands to Hold Investor Sesh IV on Friday, June 20th

LONG BEACH, Calif. and TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis …

Alterity Therapeutics Prominently Featured at the International MSA Congress

Alterity Therapeutics Prominently Featured at the International MSA Congress

– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints – – MSA Atrophy Index (MSAai) enhances MSA diagnosis and monitoring – – bioMUSE Study shows higher α- synuclein concentration is associated with greater burden …

Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%

Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%

BELO HORIZONTE, Brazil, May 12, 2025 (GLOBE NEWSWIRE) -- Inter…

BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC

BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC

PALO ALTO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire abstract and two moderated …

HOT DADS WANTED: Habit Burger & Grill X UFC GYM Launch Bold Search for the Hottest Dads in America for Summer Calendar

HOT DADS WANTED: Habit Burger & Grill X UFC GYM Launch Bold Search for the Hottest Dads in America for Summer Calendar

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- The grill is hot. The salads are hotter. And now, so are the dads. Habit Burger …

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

BETHESDA, Md., May 12, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient

Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient

Longeveron selected as a Top 40 Semifinalist based on the feasibility of its stem cell therapy Stem cell therapy laromestorcel being evaluated as potential treatment for Alzheimer’s disease and HLHS, a rare pediatric disease and orphan-designated …

Sportradar Reports First Quarter Results

Sportradar Reports First Quarter Results

First Quarter 2025 Highlights Revenue increased 17% to €311 million Profit for the period increased to €24 million and expanded to 7.8% as a percentage of revenue Adjusted EBITDA1 increased 25% to €59 million and Adjusted EBITDA margin1 expanded to 18.9% …

Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

The Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target of 25% by 2025, ahead of schedule Teva launched two new programs to help people around the world access the medicines they need, …

InStride Named a 2025 World’s Top EdTech Company by TIME and Statista

InStride Named a 2025 World’s Top EdTech Company by TIME and Statista

LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education benefits and skills development solutions, has been recognized on the TIME World’s Top EdTech Companies 2025 list, ranking #26 globally and #7 among U.S.- …

MADD Canada and RCMP Host Third Annual Constable Heidi Stevenson’s Watch Award

MADD Canada and RCMP Host Third Annual Constable Heidi Stevenson’s Watch Award

DARTMOUTH, Nova Scotia, May 12, 2025 (GLOBE NEWSWIRE) -- Police officers across Nova Scotia will be recognized at MADD Canada’s third annual Constable Heidi Stevenson’s Watch Award ceremony for their outstanding efforts to remove impaired drivers from the …

MADD Canada et la GRC présentent la troisième remise annuelle des prix Constable Heidi Stevenson’s Watch

MADD Canada et la GRC présentent la troisième remise annuelle des prix Constable Heidi Stevenson’s Watch

DARTMOUTH, Nouvelle-Écosse, 12 mai 2025 (GLOBE NEWSWIRE) -- Des policiers de la Nouvelle-Écosse seront reconnus lors de la troisième cérémonie annuelle de remise des prix Constable Heidi Stevenson’s Watch de MADD Canada pour leurs efforts exceptionnels …

Chuck E. Cheese Debuts Exclusive New Dippin’ Dots® Flavor: ‘Chuck E.'s Cookie Crunch’

Chuck E. Cheese Debuts Exclusive New Dippin’ Dots® Flavor: ‘Chuck E.'s Cookie Crunch’

DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- Chuck E. Cheese has partnered with Dippin’ Dots® to launch an exclusive new flavor, Chuck E.'s Cookie Crunch, now available only at Chuck E. Cheese locations nationwide. This marks the first Dippin’ Dots flavor to …

U.S. Energy Corp. to Participate in the D. Boral Capital Inaugural Global Conference

U.S. Energy Corp. to Participate in the D. Boral Capital Inaugural Global Conference

HOUSTON, May 12, 2025 (GLOBE NEWSWIRE) -- U.S. Energy Corp (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing assets, announced today that it will participate in the D. …

Enthusiast Gaming to Announce 1st Quarter 2025 Results on May 15th, 2025

Enthusiast Gaming to Announce 1st Quarter 2025 Results on May 15th, 2025

LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX:EGLX) will report financial and operating results for its first quarter ending on March 31st, 2025, on Thursday, May 15th, 2025, after …

Replicawrist Unveils Premium Selection of 1:1 Swiss Movement Super Clone Replica Watches for Sale

Replicawrist Unveils Premium Selection of 1:1 Swiss Movement Super Clone Replica Watches for Sale

SAUKVILLE, Wis., May 12, 2025 (GLOBE NEWSWIRE) -- In today’s world, replica watches have gained significant popularity among consumers who desire the prestige of luxury timepieces without paying a premium price. These replicas are crafted to resemble high- …

Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4

Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4

ZUG, Switzerland, May 12, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such …

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

- Announced Positive Interim Data From Ongoing Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) in Patients with Advanced Colorectal Cancer (CRC) - - Initiated CX-2051 Phase 1 dose expansions at 7.2 mg/kg, 8.6 mg/kg, and 10 mg/kg …

KANZHUN LIMITED to Report First Quarter 2025 Results on May 22, 2025

KANZHUN LIMITED to Report First Quarter 2025 Results on May 22, 2025

BEIJING, May 12, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will report its unaudited consolidated results for the first …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service